Chemours

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Chemical Solutions segment refers to the sale of chemicals used in industrial and consumer applications in the Americas. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Chemours overcomes Q4 challenges, eyes growth and sustainability in 2023

Chemours had a tough Q4 but a successful year overall, with a focus on margin improvement, growth in key businesses, and addressing legacy issues. The company is optimistic about 2023, emphasizing sustainability-led growth and returning value to shareholders.

Chemours reports strong Q1 performance, navigates challenges, eyes growth opportunities

Chemours' Q1 2023 Earnings Call highlighted strong performance, reaffirmed guidance, and emphasized margin improvement strategies. The company faces challenges from macroeconomic uncertainties and inflationary pressures but sees opportunities in sustainable initiatives and market-led innovation. Chemours remains confident in its full-year outlook and growth strategies.

Chemours reports record results, eyes cost reduction and innovation

Chemours had a strong quarter with record results and notable achievements in facility closures and settlements. While challenges lie ahead with a weaker second half expected, the company remains focused on shareholder value and strategic priorities. Opportunities in cost reduction, innovation, and market leadership position Chemours for future growth.

Chemours addresses challenges, eyes growth in sustainable solutions market

Chemours Company navigated challenges in Q3 2023, with a focus on long-term shareholder value and strategic transformation for performance improvement.
Strong performance in Performance Solutions and TSS business, alongside cost savings initiatives, position Chemours for future growth and margin recovery.
Management's commitment to driving value for shareholders amidst industry challenges underscores a proactive approach to addressing market dynamics.

Chemours reports Q4 sales growth, addresses TiO2 market challenges

Chemours is navigating challenges in the TiO2 market while focusing on cost reduction and growth opportunities in other segments. The company aims to maintain competitiveness through strategic decisions and investments in R&D. Analysts' inquiries during the earnings call highlighted concerns about leadership stability and various segment dynamics.

Chemours reports mixed Q1 results, eyes sequential growth in 2024

Chemours' Q1 2024 performance reflected mixed results across segments, with a focus on cost efficiencies, transformation plans, and maintaining liquidity amidst declining net sales and EBITDA.
Despite challenges in certain segments and market uncertainties, Chemours remains optimistic about sequential growth in the second quarter, aiming for significant EBITDA potential in 2024 and long-term financial improvement.
Strategic strengths in cost management, growth initiatives, and market opportunities position Chemours to navigate challenges, drive growth, and enhance profitability in a dynamic business environment.

Chemours exceeds volume expectations amidst challenges, anticipates sequential decline

Chemours demonstrated resilience and growth in key product lines despite facing challenges in Q1 and Q2.
The company's cost-saving efforts and recovery in certain segments highlight its ability to adapt to market conditions.
While financial results were impacted by one-time costs and a decline in net sales, Chemours maintained a strong net leverage ratio.
Anticipated sequential decline in net sales for Q3 underscores the need for strategic planning and operational optimization.

Chemours reports strong Q3 performance amidst strategic growth initiatives

Chemours' Q3 performance reflects operational strength and growth in key segments.
Challenges include declines in net sales for TSS and TT in Q4 and a net loss.
Opportunities exist in cost savings, growth in Opteon refrigerants, and strategic investments.
Overall, Chemours remains confident in its strategy to drive shareholder value.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Other. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Other segment consists of performance chemicals and intermediates business. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

Shareholders that lost money on The Chemours Company(CC) should contact Levi & Korsinsky about Securities Fraud Investigation - CC

Chemours faces operational challenges and accounting irregularities, but its position in refrigerants and crucial chemicals offers significant growth potential, outweighing current risks. Despite a 10% stock drop, 2Q24 results show resilience with $1.5B in sales and strong performance in the Titanium and Opteon segments. The company's liquidity remains strong, with over $1.5B available, and ongoing cost-saving measures are expected to drive future growth.

Chemours: We're Back Down To Trough And A 'BUY'

MINNEAPOLIS--(BUSINESS WIRE)---- $CC #classaction--A lawsuit says homes contain carpets infused with PFAS or “forever chemicals,” which manufacturers attempted to cover up, according to Hagens Berman.

Consumer Protection Law Firm Hagens Berman Sues 3M, Others in Class Action Alleging PFAS “Forever Chemicals” in Millions of Carpets

NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

CC STOCK ALERT: Levi & Korsinsky Notifies The Chemours Company Investors of an Ongoing Investigation

Lost Money on The Chemours Company (CC)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

The Chemours Company INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by The Chemours Company (CC)

NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

ATTENTION CC SHAREHOLDERS: Investors who lost money on The Chemours Company are urged to contact Levi & Korsinsky about an ongoing investigation

NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

Levi & Korsinsky Announces an Investigation on Behalf of The Chemours Company (CC) Shareholders Who May Have Been Affected by Fraud

NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.

CC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Clients to Contact the Firm!

NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.

CC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Shareholders to Contact the Firm Today!

NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

ATTENTION The Chemours Company Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights

NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.

The Chemours Company (CC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

CC ACTIVE INVESTIGATION: Contact Levi & Korsinsky if You Lost Money on Your The Chemours Company Investment

NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.

CC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Shareholders to Contact the Firm Today!

NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.

CC STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Investors to Contact the Firm Today!

NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

Lost Money on The Chemours Company(CC)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

LOS ANGELES, CA / ACCESSWIRE / August 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Shareholders With Losses In The Chemours Company Encouraged To Join Fraud Investigation With The Schall Law Firm

CC ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of The Chemours Company Shareholders Who Lost Money

NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.

CC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Investors to Contact the Firm Today!

NEW YORK, NY / ACCESSWIRE / August 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

Investors who lost money on The Chemours Company should contact Levi & Korsinsky about an ongoing investigation - CC

LOS ANGELES, CA / ACCESSWIRE / August 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Chemours Company Investors Invited To Participate In Fraud Investigation With The Schall Law Firm

NEW YORK, NY / ACCESSWIRE / August 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE:CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC.

CC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into The Chemours Company and Encourages Investors to Contact the Firm Today!

NEW YORK, NY / ACCESSWIRE / August 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

Did The Chemours Company Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - CC

LOS ANGELES, CA / ACCESSWIRE / August 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Chemours Company Shareholders Encouraged To Join Fraud Investigation With The Schall Law Firm

NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.

News for Chemours Stock (CC)